Autophagy is important in a variety of cellular and pathophysiological situations; however, its role in immune responses remains elusive. Here, we show that among B cells, germinal center (GC) cells exhibited the highest rate of autophagy during viral infection. In contrast to mechanistic target of rapamycin complex 1-dependent canonical autophagy, GC B cell autophagy occurred predominantly through a noncanonical pathway. B cell stimulation was sufficient to down-regulate canonical autophagy transiently while triggering noncanonical autophagy. Genetic ablation of WD repeat domain, phosphoinositide-interacting protein 2 in B cells alone enhanced this noncanonical autophagy, resulting in changes of mitochondrial homeostasis and alterations in GC and antibody-secreting cells. Thus, B cell activation prompts a temporal switch from canonical to noncanonical autophagy that is important in controlling B cell differentiation and fate.
M acroautophagy (hereafter called autophagy) is a conserved, lysosomal pathway that degrades cytosolic content and provides a means for cellular survival during stressful conditions. Autophagy is involved in several areas of the immune response (1, 2) . In B cells, autophagy has been described as an essential process for the maintenance of plasma cells (PCs) and survival of memory B cells (3) (4) (5) . However, given the high and stressful energy demand that B cells require following activation, we investigated the role of autophagy in the early steps of B cell activation following viral infection.
Autophagosome formation requires the localization of phosphatidylethanolamine conjugated LC3 (LC3-II) to the autophagosome membrane (6, 7) . Accordingly, LC3-II accumulation was used to examine the role of autophagy in vivo during the course of an immune response. Transgenic mice expressing LC3 fused to a green fluorescent protein (GFP-LC3) were infected with murid herpesvirus-4 (MuHV-4), and spleen sections were examined.
Germinal center (GC) B cells characterized by Bcl6
high IgD low staining exhibited higher levels of GFP-LC3 staining compared with Bcl6 low IgD high mantle cells (surround GC) (Fig. 1A) . Similar results were observed after the addition of chloroquine, an inhibitor that prevents the lysosomal breakdown of autophagosomes, compared with antibody-secreting cells (ASCs) (fig. S1, A and B). Flow cytometry analysis also revealed that GC B cells had a greater than two-times increase in vesicular GFP-LC3-II compared with follicular B cells (Fig. 1B) .
Next, we examined the autophagic flux in B cells by visualizing the accumulation of GFP-LC3-II using two commonly used autophagy inhibitors, bafilomycin A1 (BafA1) or chloroquine, which block LC3-II degradation differently (8) . Whereas a comparable block in autophagy flux was observed in the different B cell types (follicular, GC, ASC, and memory) after treatment with BafA1 (Fig. 1C) , a significantly increased flux was observed only in GC B cells in response to chloroquine (Fig. 1, C and D, and fig. S1 , C to F). This increased LC3-II flux in GC B cells was recapitulated in chloroquine-treated spleen tissue ( fig. S1A) .
The results from flow cytometry analyses were quantitated using an autophagy index (AI), wherein we defined total autophagy flux as the mean fluorescence intensity (MFI) after chloroquine treatment, canonical autophagy flux as the MFI after BafA1 treatment, and the noncanonical autophagy flux as the difference between the two normalized by the MFI of LC3-II before inhibitor addition (Fig. 1C and fig. S1D ). When GC cells were subdivided into centrocytes (light zone) and centroblasts (dark zone), both cell populations showed an elevated noncanonical autophagy flux, with centrocytes exhibiting a reduction in canonical autophagy flux compared to centroblasts (Fig. 1E and fig. S1 , G and H). Thus, GC B cells not only have the highest LC3-II levels but also exhibit an atypical flux.
B cell receptor (BCR) stimulation of naïve follicular cells was sufficient to inhibit the canonical accumulation of LC3-II while at the same time triggering the increase of noncanonical accumulation of LC3-II (Fig. 1F and fig. S2 , A to C). Consistent with a diminution in canonical autophagy, levels of p62 (a receptor protein for cargo degraded by autophagy) increased ( fig. S2D ), indicating that upon activation B cells switch from canonical to noncanonical accumulation of LC3-II. In vitro, the levels of canonical autophagy were restored 1 day after stimulation (Fig. 1G and fig. S3A ); however, total autophagy peaked 2 days following stimulation. At this point, LC3-II could be detected by immunoblot even in the absence of any inhibitor ( fig. S3B ). Furthermore, a similar switch in autophagy was apparent when B cells were activated by other means such as CD40 stimulation ( fig. S2 , A to C).
Canonical autophagy is triggered by the inactivation of mechanistic target of rapamycin complex 1 (mTORC1) (9) . However, in activated B cells, the mTORC1 substrate, phosphorylated ribosomal protein S6 kinase (p-pS6K), was significantly elevated (10, 11) [10-fold upon BCR crosslinking ( Fig. 2A ) and at least 2-fold in GC B cells (Fig. 2B) ]. This mTORC1 activity decreased after 20 hours of stimulation, consistent with a restoration of the levels of canonical autophagy (Fig. 1G, Fig. 2A, and fig. S3A ). Furthermore, this atypical autophagy flux was dependent on SYK, PLCg2, BLNK, VAV, and PI3K activity but apparently not on class III PI3K required for canonical autophagy (12, 13) (Fig. 2, C and D, and fig. S4 , A to C). Thus, the noncanonical accumulation of LC3-II in activated B cells might become physiologically relevant when the levels of mTORC1 are high.
We next followed the intracellular recruitment of four components of the autophagy machinery-ATG9L1, ATG16L1, WD repeat domain, phosphoinositide-interacting protein 2 (WIPI2), and LC3 (14)-in A20 B cells following BCR stimulation in real-time using total internal reflection fluorescence (TIRF) microscopy. Although we observed some colocalization of the early autophagy marker ATG9 to antigen clusters ( Fig. 2E and movie S1), we were unable to detect any recruitment of WIPI2, ATG16L1, and LC3, suggesting that these proteins might be recruited later during antigen internalization ( fig.  S5 , A to C, and movies S2 to S4). To analyze this further, we used structured illumination microscopy (SIM) to localize WIPI2 and ATG16L1 in wild-type (WT) primary naïve B cells following BCR stimulation. Fifteen minutes after BCR stimulation, the internalized antigen was present in ringlike structures decorated with WIPI2 or ATG16L1 ( Fig. 2F and movies S5 to S7). A closer analysis of the antigen-containing ringlike structures using a combination of correlative SIM and transmission electron microscopy (TEM) suggested that the antigen-containing ringlike structures might be constituted predominantly of a single membrane ( Fig. 2G and movie S7) . These results indicate an early recruitment of the autophagy membrane during B cell activation as well as an accumulation of autophagy proteins to unusual ringlike structures, which surround the internalized antigen.
Given the colocalization of antigen with WIPI2 and ATG16L1, we wanted to elucidate the role of this pathway in B cell activation following a genetic approach. We conditionally deleted ATG16L1 in B cells by crossing Atg16l1 flox/flox mice with mice expressing cre recombinase from either MB1 or Cd19 promoters. With the exception of a reduction of B1a cells in the peritoneal cavity, ATG16L1-knockout (KO) B cells developed normally and were phenotypically indistinguishable from those of their WT littermates (figs. S6 and S7). Our attempts to conditionally ablate WIPI2 in the B cell compartment resulted in mice expressing low amounts of an aberrant version of WIPI2 (WIPI2-KO P mice) ( fig. S8, A and C) . Therefore, we developed a second WIPI2-KO line of mice using the CRISPR (clustered regularly interspaced short palindromic repeats)-Cas9 technology, which led to complete WIPI2 deletion (fig. S8, B and C) . In order to study the function of WIPI2 in B cells, we took advantage of WIPI2-KO P bone marrow (BM) and WIPI2-KO fetal liver (FL) to generate mixed chimeras (materials and methods in Martinez supplementary materials). In both WIPI2-KO and WIPI2-KO P mice, B cells developed and differentiated normally giving rise to normal numbers of B cells in the spleen, but they lacked the B1 compartment (figs. S9 and S10).
Upon antigen challenge, the WIPI2-KO and WIPI2-KO P chimeras showed a significant reduction in GC B cells and a diminution of centroblasts during B cell immune response (Fig. 3, A and B,  and fig. S11, C and G) . Whereas the percentage of ASCs was substantially reduced in the WIPI2-KO mice, there was an increase of these cells in the WIPI2-KO P mice (Fig. 3B) . Consistent with these results, we observed enhanced levels of immunoglobulin M (IgM) but decreased immunoglobulin G (IgG) in WIPI2-KO P mice and reduced frequency of IgG-producing cells using an enzymelinked immunospot (ELISPOT) assay (fig. S11, D  and E) . Finally, we found statistically insignificant reduction of memory cells in WIPI2-KO mice ( fig.  S11F ). However, ATG16L1-KO mice did not exhibit such marked immune alterations when compared to their WT littermates (Fig. 3, A and B, and  fig. S11, A and B) . Thus, GC B cell formation and ASCs differentiation require WIPI2 and, to a lesser degree, ATG16L1.
To study the effect of WIPI2 and ATG16L1 deletion on B cell autophagy, LC3-II accumulation was examined in naïve, stimulated B cells and GC B cells in the presence and absence of chloroquine and BafA1 with flow cytometry. As expected, ablation of ATG16L1 led to a complete absence of LC3-II under all treatment conditions (Fig. 3, C  and D, and fig. S13A) . Surprisingly, WIPI2-deficient naïve B cells exhibited elevated levels of LC3-II even in the absence of stimulation or the presence of any inhibitor (Fig. 3C and fig. S12A ). Furthermore, compared to WT B cells, both resting and BCR-stimulated WIPI2-KO B cells exhibited a twofold higher LC3-II accumulation after chloroquine, but not BafA1, treatment (Fig. 3, C and D, and figs. S12, A and B, and S13B), indicating that these B cells lack canonical autophagy while having enhanced noncanonical LC3-II accumulation. Similar results were obtained in naïve B cells lacking ULK1/ULK2 or when Beclin-1 or WIPI2 were genetically ablated in B cell lines, adding to the notion that this is the result of noncanonical accumulation of LC3 ( fig. S12,  C to F) . Additionally, the accumulation of p62 in WIPI2-KO cells is indicative of the lack of canonical autophagy, which was also what we observed in ATG16L1-KO cells ( fig. S12G ). Consistent with the notion of a key role for WIPI2 in the GC, the expression of this protein was enhanced 10-fold in GCs compared to other B cell types ( fig. S12H) . Thus, whereas canonical autophagy is abolished in ATG16L1-and WIPI2-deficient B cells, WIPI2-KO cells exhibit a higher noncanonical accumulation of LC3-II.
We then determined the effect of WIPI2 and ATG16L1 ablation on B cell proliferation and differentiation in vitro. We tracked B cell division and ASC differentiation according to the dilution of CTV (CellTrace Violet dye) and the appearance of CD138
+ cells, respectively, in CpG-stimulated B cells isolated from WIPI2-KO, ATG16L1-KO, or WT mice. Whereas the proliferation of both ATG16L1-KO and WIPI2-KO B cells was comparable to that of WT, the number of ASCs was significantly higher in WIPI2-KO cells (Fig. 4A and  fig. S14A ). Compared to WT cells, which require at least three divisions to acquire ASC markers, WIPI2-KO B cells needed only two cell divisions (Fig. 4A and fig. S14A ). Similar results were obtained when B cells were treated with resveratrol, an agent known to induce Beclin-1-independent noncanonical autophagy ( fig. S15, A and B) (9) . Thus, the absence of WIPI2, but not ATG16L1, is sufficient to enhance differentiation to ASCs in vitro, likely owing to higher levels of noncanonical LC3 accumulation in WIPI2-KO cells.
Upon antigenic challenge, both WIPI2-and ATG16L1-deficient cells were capable of forming antigen-containing ring structures; however, unlike B cells lacking ATG16L1, WIPI2-deficient B cells had more antigen-containing ringlike structures compared to WT after 15 min or after 5 hours of BCR stimulation in the presence of chloroquine ( Fig. 4B; fig. S16 , A and B; and movie S8). Thus, the absence of WIPI2, but not ATG16L1, might cause cellular alterations affecting antigen internalization. Intriguingly, correlative SIM and TEM showed mitochondrial fragments that appear to be surrounded, or even engulfed, by these rings (Fig. 4C and movie S9) .
Mitochondrial status has been suggested as a signal for initiating B cell differentiation (15) . Although no mitochondrial alterations were observed in ATG16L1-KO naïve resting B cells when compared to WT, WIPI2-KO naïve resting B cells exhibited higher levels of reactive oxygen species (ROS), mitochondrial mass (MM), and mitochondrial membrane potential (MMP) than WT cells (Fig. 4D and fig. S14B ). Additionally, both the basal oxygen consumption rate (OCR) and the basal extracellular acidification rate (ECAR) were significantly higher in WIPI2-KO B cells (Fig. 4E) . Furthermore, phosphoS65-parkin, a key mitochondrial-degradation protein involved in ubiquitin-dependent degradation and mitophagy, was increased at steady state but not following BCR stimulation in WIPI2-KO B cells (Fig. 4F) . Furthermore, following CpG stimulation, a low-MM and low-MMP mitochondrial population appeared more rapidly in WIPI2-KO cells compared to WT cells (Fig. 4G and fig. S14C ). This is consistent with the higher numbers of ASCs observed in the cultures (Fig. 4A and fig. S14A ). Similar results were also obtained when WT B cells were treated with resveratrol ( fig. S15C ). These results highlight a role for WIPI2 in mitochondrial homeostasis during B cell activation and cell differentiation.
During adaptive immune responses, B cell activation results in a highly proliferative stage, where B cells expand and differentiate either outside the follicles into short-lived PCs and early recirculating memory B cells or they enter into the GCs. In the GCs, B cell proliferation and differentiation results in the formation of long-lived PCs and memory B cells with improved affinity for the antigen. This stage is intricately linked with a switch in the metabolic program of cells toward providing building blocks for the synthesis of various biomolecules and meeting the energetic demands at the cellular level (16) . Autophagy enables recycling of macromolecules that serve as a source of building blocks and energy required for cell survival under stress. Considering this high demand for energy and resources during the differentiation of follicular B cells into GCs, it is somewhat surprising that, until now, autophagy has been described to be essential only in memory and PC survival (4, 5) . Our data highlight the importance of autophagic processes during the B cell immune response.
Overall, we have established that GC B cells exhibit increased basal levels of noncanonical LC3 accumulation, which is recapitulated when naïve B cells are activated. This increased accumulation of LC3 appears to occur through predominantly noncanonical pathways and is driven by a temporary switch that down-regulates canonical autophagy. This switch, initiated during B cell activation, might be of importance at the centrocyte stage, where GC cells are exposed to antigen stimulation and T cell help in vivo. Antigen stimulation of the B cells through BCR or T cell help increases mTOR activity (10, 11), which in turn will down-regulate canonical autophagy while inducing the noncanonical accumulation of LC3-II. These autophagy alterations might associate with endosomal regulation to allow T cell presentation as well as changes in mitochondrial homeostasis to help B cells to divide.
The absence of WIPI2, but not ATG16L1, promoted an imbalance in the amount of LC3-II and the nature of autophagy in B cells. This resulted in a lack of canonical autophagy and an increase in noncanonical accumulation of LC3-II within WIPI2-KO B cells. These changes were associated with alterations in the mitochondrial status and the metabolic profile of B cells, which affect GC reaction and ASC differentiation. We propose that WIPI2 is an important regulator of autophagy and mitochondria homeostasis in B cells and thus influences B cell differentiation and fate.
